This contract expires in 112 days (Sep 30, 2026).
FIRM FIXED PRICENO SET ASIDE USED.
BIOFIRE DEFENSE LLC - MOLECULAR INFECTIOUS DISEASE POLYMERASE CHAIN REACTION (PCR) TESTING
PIID: W81K0025PA095Solicitation ID: W81K0025QA019
Signed Date: Nov 21, 2025Effective Date: Oct 1, 2025End Date: Closes in 112 days
Award $
$1.1M
Vendor
BIOFIRE DEFENSE LLC
NAICS
325413
Signed Date
Nov 21, 2025
Key Details
Description
MOLECULAR INFECTIOUS DISEASE POLYMERASE CHAIN REACTION (PCR) TESTING
Context & Analysis
On Nov 21, 2025, Department of Defense obligated $1,084,833.75 to BIOFIRE DEFENSE LLC for molecular infectious disease polymerase chain reaction (pcr) testing. The award is classified under NAICS 325413 — IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING and issued as a firm fixed price contract. Competition extent: competed under sap with 2 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in SAN ANTONIO, TX. The contract is scheduled through Sep 30, 2026 — approximately 4 months remaining.
Contractor Information
Stay Updated
Get notified about new opportunities matching your interests.
Related
Agencies
Vendors